My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.240 +0.060 (+2.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗

August 25, 2025

Via Benzinga

1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street ↗

August 24, 2025

Time is running out for the company to mount a comeback.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

August 22, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Iovance Biotherapeutics Stock Was Climbing Today ↗

August 19, 2025

One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country.

Via The Motley Fool

Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’ ↗

August 19, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

August 18, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

August 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Stocks That Could Turn $1,000 Into $5,000 by 2030 ↗

August 09, 2025

All three of these companies are entering a period of what could produce unparalleled top- and bottom-line growth.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Plummeted Today ↗

August 08, 2025

The company's top line nearly doubled.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About Iovance Biotherapeutics ↗

August 08, 2025

Via Benzinga

Pinterest Posts Downbeat Q2 Earnings, Joins Twilio, Trade Desk And Other Big Stocks Moving Lower In Friday Pre-Market Session ↗

August 08, 2025

Via Benzinga

Which stocks are moving before the opening bell on Friday? ↗

August 08, 2025

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 08, 2025

Via Benzinga

Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening ↗

August 08, 2025

Iovance stock fell over 29% pre-market after Q2 results, despite reporting a strong revenue jump led by Amtagvi sales.

Via Benzinga

Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 07, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

August 07, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Iovance (IOVA) Q2 Revenue Jumps 93% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

August 07, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Is Iovance Biotherapeutics Stock Due for a Big Rally? ↗

July 30, 2025

The biotech stock has been picking up steam of late -- but will it last?

Via The Motley Fool

This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy? ↗

July 29, 2025

Even the average price estimate for this stock suggests it can soar, but not everyone's convinced.

Via The Motley Fool

Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025

July 24, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 24, 2025

Via Benzinga

Here are the top movers in Wednesday's session. ↗

July 23, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday ↗

July 23, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.